These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 27749739)

  • 41. Estrogen alone and joint symptoms in the Women's Health Initiative randomized trial.
    Chlebowski RT; Cirillo DJ; Eaton CB; Stefanick ML; Pettinger M; Carbone LD; Johnson KC; Simon MS; Woods NF; Wactawski-Wende J
    Menopause; 2018 Nov; 25(11):1313-1320. PubMed ID: 30358728
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Estrogen metabolism in menopausal hormone users in the women's health initiative observational study: Does it differ between estrogen plus progestin and estrogen alone?
    Falk RT; Manson JE; Barnabei VM; Anderson GL; Brinton LA; Rohan TE; Cauley JA; Chen C; Coburn SB; Pfeiffer RM; Reding KW; Sarto GE; Wentzensen N; Chlebowski RT; Xu X; Trabert B
    Int J Cancer; 2019 Feb; 144(4):730-740. PubMed ID: 30183089
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause.
    Rossouw JE; Prentice RL; Manson JE; Wu L; Barad D; Barnabei VM; Ko M; LaCroix AZ; Margolis KL; Stefanick ML
    JAMA; 2007 Apr; 297(13):1465-77. PubMed ID: 17405972
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Estrogen alone and joint symptoms in the Women's Health Initiative randomized trial.
    Chlebowski RT; Cirillo DJ; Eaton CB; Stefanick ML; Pettinger M; Carbone LD; Johnson KC; Simon MS; Woods NF; Wactawski-Wende J
    Menopause; 2013 Jun; 20(6):600-8. PubMed ID: 23511705
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Risks and benefits of menopausal hormone therapy in postmenopausal Chinese women.
    Su IH; Chen YC; Hwang WT; Liu Z; Su TP; Chen TJ; Barnhart KT; Yang YX
    Menopause; 2012 Aug; 19(8):931-41. PubMed ID: 22453198
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A(nother) scientific strategy to prevent breast cancer in postmenopausal women by enhancing estrogen-induced apoptosis?
    Jordan VC
    Menopause; 2014 Oct; 21(10):1160-4. PubMed ID: 24618769
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of Oral vs Transdermal Estrogen Therapy on Sexual Function in Early Postmenopause: Ancillary Study of the Kronos Early Estrogen Prevention Study (KEEPS).
    Taylor HS; Tal A; Pal L; Li F; Black DM; Brinton EA; Budoff MJ; Cedars MI; Du W; Hodis HN; Lobo RA; Manson JE; Merriam GR; Miller VM; Naftolin F; Neal-Perry G; Santoro NF; Harman SM
    JAMA Intern Med; 2017 Oct; 177(10):1471-1479. PubMed ID: 28846767
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Conjugated equine estrogens and coronary heart disease: the Women's Health Initiative.
    Hsia J; Langer RD; Manson JE; Kuller L; Johnson KC; Hendrix SL; Pettinger M; Heckbert SR; Greep N; Crawford S; Eaton CB; Kostis JB; Caralis P; Prentice R;
    Arch Intern Med; 2006 Feb; 166(3):357-65. PubMed ID: 16476878
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Noncardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II).
    Hulley S; Furberg C; Barrett-Connor E; Cauley J; Grady D; Haskell W; Knopp R; Lowery M; Satterfield S; Schrott H; Vittinghoff E; Hunninghake D;
    JAMA; 2002 Jul; 288(1):58-66. PubMed ID: 12090863
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Conjugated equine estrogens and breast cancer risk in the Women's Health Initiative clinical trial and observational study.
    Prentice RL; Chlebowski RT; Stefanick ML; Manson JE; Langer RD; Pettinger M; Hendrix SL; Hubbell FA; Kooperberg C; Kuller LH; Lane DS; McTiernan A; O'Sullivan MJ; Rossouw JE; Anderson GL
    Am J Epidemiol; 2008 Jun; 167(12):1407-15. PubMed ID: 18448442
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study.
    Espeland MA; Rapp SR; Shumaker SA; Brunner R; Manson JE; Sherwin BB; Hsia J; Margolis KL; Hogan PE; Wallace R; Dailey M; Freeman R; Hays J;
    JAMA; 2004 Jun; 291(24):2959-68. PubMed ID: 15213207
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Women's Health Initiative estrogen plus progestin clinical trial: a study that does not allow establishing relevant clinical risks.
    Aedo S; Cavada G; Blümel JE; Chedraui P; Fica J; Barriga P; Brantes S; Irribarra C; Vallejo M; Campodónico Í
    Menopause; 2015 Dec; 22(12):1317-22. PubMed ID: 25968833
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial.
    Shumaker SA; Legault C; Rapp SR; Thal L; Wallace RB; Ockene JK; Hendrix SL; Jones BN; Assaf AR; Jackson RD; Kotchen JM; Wassertheil-Smoller S; Wactawski-Wende J;
    JAMA; 2003 May; 289(20):2651-62. PubMed ID: 12771112
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of Hormone Therapy on Intraocular Pressure: The Women's Health Initiative-Sight Exam Study.
    Vajaranant TS; Maki PM; Pasquale LR; Lee A; Kim H; Haan MN
    Am J Ophthalmol; 2016 May; 165():115-24. PubMed ID: 26940165
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of postmenopausal hormone therapy on incident atrial fibrillation: the Women's Health Initiative randomized controlled trials.
    Perez MV; Wang PJ; Larson JC; Virnig BA; Cochrane B; Curb JD; Klein L; Manson JE; Martin LW; Robinson J; Wassertheil-Smoller S; Stefanick ML
    Circ Arrhythm Electrophysiol; 2012 Dec; 5(6):1108-16. PubMed ID: 23169946
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of estrogen plus progestin on gynecologic cancers and associated diagnostic procedures: the Women's Health Initiative randomized trial.
    Anderson GL; Judd HL; Kaunitz AM; Barad DH; Beresford SA; Pettinger M; Liu J; McNeeley SG; Lopez AM;
    JAMA; 2003 Oct; 290(13):1739-48. PubMed ID: 14519708
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Combined conjugated esterified estrogen plus methyltestosterone supplementation and risk of breast cancer in postmenopausal women.
    Kabat GC; Kamensky V; Heo M; Bea JW; Hou L; Lane DS; Liu S; Qi L; Simon MS; Wactawski-Wende J; Rohan TE
    Maturitas; 2014 Sep; 79(1):70-6. PubMed ID: 25011395
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Scientific rationale for postmenopause delay in the use of conjugated equine estrogens among postmenopausal women that causes reduction in breast cancer incidence and mortality.
    Obiorah I; Jordan VC
    Menopause; 2013 Apr; 20(4):372-82. PubMed ID: 23921472
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Incidence of cervical cytological abnormalities with aging in the women's health initiative: a randomized controlled trial.
    Yasmeen S; Romano PS; Pettinger M; Johnson SR; Hubbell FA; Lane DS; Hendrix SL
    Obstet Gynecol; 2006 Aug; 108(2):410-9. PubMed ID: 16880313
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of estrogen therapy on gallbladder disease.
    Cirillo DJ; Wallace RB; Rodabough RJ; Greenland P; LaCroix AZ; Limacher MC; Larson JC
    JAMA; 2005 Jan; 293(3):330-9. PubMed ID: 15657326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.